Solitary chemosensory cell development and function
孤立化学感应细胞的发育和功能
基本信息
- 批准号:10194193
- 负责人:
- 金额:$ 5.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-05 至 2021-10-01
- 项目状态:已结题
- 来源:
- 关键词:AddressAgonistAllergicAreaBehaviorCalciumCell CommunicationCell CountCell Culture TechniquesCell Differentiation processCell LineageCell physiologyCellsCellular biologyChemical StructureChemicalsConfocal MicroscopyDataDetectionDevelopmentDiseaseElementsEnvironmentEpithelialEpithelial CellsFamilyGene TransferGoalsHealthHeterogeneityHomeostasisHouse Dust Mite AllergensHumanImmune responseImmunofluorescence ImmunologicImmunologyIncidenceInflammatoryInterleukin-13IrritantsKineticsKnowledgeLabelLaboratoriesLigandsLungMentorsMethodologyMethodsMissionModelingMolecularMorphologyMucosal ImmunityMusNeuroendocrine CellPopulation HeterogeneityPublicationsQuality of lifeQuantitative Reverse Transcriptase PCRReporterResearchRodentRoleSensorySignal TransductionStructure of respiratory epitheliumSystemTRPM5 geneTaste BudsTaste PerceptionTestingTimeTissuesTransgenic MiceTranslatingUnited States National Institutes of HealthWorkairborne allergenairway epitheliumairway surface liquidbaseburden of illnesscell typecigarette smokecohesionconfocal imagingcytokinedisabilityeffective therapyepithelial repairhuman diseasehuman studyhuman tissuein vivoinnovationinsightinterestmicrobialmouse modelnovelnovel strategiespollutantprecursor cellprogenitorpromoterreceptorrespiratoryresponseresponse to injurysingle-cell RNA sequencingtaste transductiontooltranscriptome sequencing
项目摘要
PROJECT SUMMARY
Novel approaches to airway epithelial study have broadened our understanding of its diverse cellular
makeup, developmental regulators, response to injury, and cell interactions involved in local tissue function.
Recent work by our group and others has demonstrated a role for airway solitary chemosensory cells (SCCs)
in detection of irritants within the airway surface liquid, signal transduction through canonical bitter taste
signaling effectors, and initiation of a multifaceted immune response. Interestingly, lineage implications from
RNAseq based approached in mouse and human lung studies suggest a possible relationship between SCCs
and other rare airway cell types including the ionocyte and the neuroendocrine cell.
Our central hypothesis is that human SCCs encompass a heterogeneous population that is modulated in
the allergic inflammatory setting, and uniquely express cell-specific chemosensory receptors to detect human
disease-associated compounds. This hypothesis has been formulated on the basis of publications and
preliminary data produced in the applicant's laboratory during the K23 mentored research period, and Co-I
Vladar's long-standing interest in airway epithelial repair. To test this—and generate tools for further
mechanistic study—we will utilize a platform of retroviral gene transfer to genetically modify SCCs in human
cell culture. We will pursue two aims: (1) characterization of SCC differentiation using the hTRPM5p-GFP
lentiviral reporter in normal and allergic human primary sinonasal epithelial cell culture; and (2) test human
SCC functional responses to disease-associated airborne irritants using a real-time TRPM5-mCherry/GCaMP6
Ca2+ reporter in primary HSNEC culture.
Our long-term goal is to determine the functional role(s) of SCCs and chemosensory cell types in airway
epithelial homeostasis, and to translate these findings into a cohesive understanding of airway mucosal
immunity in human health and disease. Notably, limitations of available methods for labeling and isolating this
rare cell type from human tissues have resulted in challenges in translating findings from mouse to human.
This innovative proposal represents a significant conceptual departure from the status quo, and will utilize
novel methodologies to test specific hypotheses and for general discovery in an area where little is known. The
proposed research is significant because it is expected to advance understanding of how SCCs function as
environmental sensory that regulate epithelial homeostasis. Ultimately, such knowledge has the potential to be
developed into effective therapies for inflammatory airway disorders, a pressing need given the significant
incidence and burden of these diseases.
项目总结
呼吸道上皮细胞研究的新方法拓宽了我们对其不同细胞的理解
组成、发育调节、对损伤的反应以及与局部组织功能有关的细胞相互作用。
我们小组和其他人最近的工作证明了呼吸道孤立性化学感觉细胞(Scc)的作用。
在检测呼吸道表面液体中的刺激物时,通过典型的苦味进行信号转导
信号效应器,以及启动多方面的免疫反应。有趣的是,来自
基于RNAseq的小鼠和人肺研究提示鳞状细胞之间可能存在关系
以及其他罕见的呼吸道细胞类型,包括离子细胞和神经内分泌细胞。
我们的中心假设是,人类的干细胞包含了一个异质的种群,这种种群受到
过敏性炎症环境,并独特地表达细胞特异性化学感觉受体来检测人类
与疾病相关的化合物。这一假设是在各种出版物的基础上提出的
申请人的实验室在K23指导研究期间产生的初步数据,以及Co-I
Vladar对呼吸道上皮修复的长期兴趣。为了测试这一点-并生成工具以进一步
机制研究-我们将利用逆转录病毒基因转移平台对人类的干细胞进行基因改造
细胞培养。我们将追求两个目标:(1)用hTRPM5P-GFP表征鳞状细胞分化
慢病毒在正常人和变态反应性人鼻腔上皮细胞培养中的表达;以及(2)测试人
实时Trpm5-mCherry/GCaMP6对疾病相关气载刺激物的SCC功能反应
原代HSNEC培养中有钙离子报告。
我们的长期目标是确定干细胞在呼吸道中的功能作用(S)和化学感觉细胞类型
上皮动态平衡,并将这些发现转化为对呼吸道粘膜的凝聚力理解
免疫在人类健康和疾病中的作用。值得注意的是,可用于标记和隔离该病毒的方法的局限性
人类组织中罕见的细胞类型导致了将研究结果从小鼠转化为人类的挑战。
这一创新的提议在概念上与现状有很大的不同,并将利用
测试特定假设和在一个鲜为人知的领域中进行普遍发现的新方法。这个
拟议的研究具有重要意义,因为它有望促进对干细胞如何发挥作用的理解
调节上皮细胞动态平衡的环境感官。最终,这样的知识有可能成为
发展成为治疗炎症性呼吸道疾病的有效疗法,这是一项紧迫的需求,因为
这些疾病的发病率和负担。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Vijay Ramakrishnan其他文献
Vijay Ramakrishnan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Vijay Ramakrishnan', 18)}}的其他基金
Solitary chemosensory cell development and function
孤立化学感应细胞的发育和功能
- 批准号:
10379276 - 财政年份:2021
- 资助金额:
$ 5.49万 - 项目类别:
Solitary chemosensory cell development and function
孤立化学感应细胞的发育和功能
- 批准号:
10539379 - 财政年份:2021
- 资助金额:
$ 5.49万 - 项目类别:
Role of taste signaling in airway epithelial function
味觉信号在气道上皮功能中的作用
- 批准号:
9810731 - 财政年份:2015
- 资助金额:
$ 5.49万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 5.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 5.49万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 5.49万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 5.49万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 5.49万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 5.49万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 5.49万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 5.49万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 5.49万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 5.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)